CVS (CVS) disappointed Wall Street Wednesday by missing revenue estimates and revising down its 2024 guidance and expects to raise insurance plan prices in the coming year as it adjusts for Medicare ...
Diversified healthcare company CVS Health (NYSE:CVS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.60 ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. CVS Health easily beat fourth-quarter ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results